Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04UFY
|
|||
| Former ID |
DIB016285
|
|||
| Drug Name |
UX-003
|
|||
| Indication | Lysosomal storage disease [ICD-11: 5C56.Z; ICD-10: E75-E77] | Phase 3 | [1] | |
| Mucopolysaccharidosis [ICD-11: 5C56.3] | Phase 3 | [2] | ||
| Company |
Ultragenyx Pharmaceutical
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02230566) A Phase 3 Study of UX003 rhGUS Enzyme Replacement Therapy in Patients With MPS 7. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.